Shanghai NOVRIBO (a wholly-owned subsidiary of Shanghai Desano Group which was established in 1996), established in 2021,is an innovation-oriented comprehensive enterprise focusing on Research &Development ,manufacturing raw materials and intermediates for DNA series, mRNA vaccines,ASO,SiRNA,RNAi,etc nucleic acid medicines.We have an R&D center in Shanghai Zhangjiang Hi-tech Park ,and 4manufacturing sites individually located in Shanghai、Anhui 、Nei Mongolia and Jiangsu Province producing 2’-Deoxynucleosides、 Modified and Protected Nucleosides, DNA&RNA Amidites、 P-reagents and Solid supports .

We also have the capacity to custom-synthesize products on request.

We devote to giving our customers first-class products and best service.